US FDA declines to approve Aldeyra's drug for eye disorder-March 2024-www.financetom.com

US FDA declines to approve Aldeyra's drug for eye disorder

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA declines to approve Aldeyra's drug for eye disorder

Mar 17, 2026 6:09 AM

March 17 (Reuters) - The U.S. Food and Drug

Administration on Tuesday declined to approve Aldeyra

Therapeutics' ( ALDX ) drug for a type of eye disease, the

company said.

Previous page： Japan's trade minister to visit US in March for tariff talks, Asahi reports Next page： Trump says he will announce a range of tariffs over 'next month or sooner'

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Japan's trade minister to visit US in March for tariff talks, Asahi reports

Feb 19, 2025

Feb 20 (Reuters) - Japan's Trade Minister Yoji Muto plans to visit the United States in March and ask the Trump administration to exempt Japan from upcoming tariffs on steel and cars, the Asahi newspaper reported on Thursday. Muto is arranging meetings with newly confirmed U.S. Commerce Secretary Howard Lutnick, Energy Secretary Chris Wright and other top officials also to...

Trump says he will announce a range of tariffs over 'next month or sooner'

Feb 19, 2025

By Andrea Shalal and Kanishka Singh MIAMI (Reuters) -U.S. President Donald Trump said on Wednesday he will announce tariffs related to lumber, cars, semiconductors and pharmaceuticals over the next month or sooner. I'm going to be announcing tariffs on cars and semiconductors and chips and pharmaceuticals, drugs and pharmaceuticals and lumber, probably and some other things over the next month...

BRIEF-Lightpath Technologies Announces Closing Of Acquisition Of G5 Infrared

Feb 19, 2025

Feb 19 (Reuters) - LightPath Technologies Inc ( LPTH ): * LIGHTPATH TECHNOLOGIES ANNOUNCES CLOSING OF ACQUISITION OF G5 INFRARED LLC Source text: Further company coverage: ...

Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 19, 2025

NEW YORK(Reuters) - Life sciences investment firm Deep Track Capital is launching a board fight at Dynavax Technologies ( DVAX ), pressing for new directors to prioritize the development of the company's hepatitis B vaccine instead of pursuing new acquisitions. Deep Track nominated four candidates to Dynavax's ( DVAX ) board to add industry and financial expertise plus a shareholder's...